Published on GHDx (https://ghdx.healthdata.org)

Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China

General Info

Geography 
China (CHN)
Coverage type 
Country
Time period covered 
January, 2011 - December, 2012
Data type
Scientific literature
Keywords 
Diabetes

Citation

Authors 
Shi G, Zhu N, Qiu L, Yan H, Zeng L, Wang D, Dang S, Li Z, Kang Y, Chen T, Li C
Journal 
Int J Gen Med
Pages 
6639-6645
Publication year 
2021
Suggested citation 
Shi G, Zhu N, Qiu L, Yan H, Zeng L, Wang D, Dang S, Li Z, Kang Y, Chen T, Li C. Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China. Int J Gen Med. 2021; 14: 6639-6645.
Source URL:https://ghdx.healthdata.org/record/impact-2020-china-diabetes-society-guideline-prevalence-diabetes-mellitus-and-eligibility#comment-0